Quarterly report pursuant to Section 13 or 15(d)

Derivative Instruments and Hedging Activities (Tables)

v3.8.0.1
Derivative Instruments and Hedging Activities (Tables)
 9 Months Ended
Sep. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Value Amounts of Liability Derivative
Information about the fair value amounts of the Company’s derivative instruments is as follows:
 
Derivatives as of
 
September 30, 2017
 
December 31, 2016
 
Balance Sheet Location
 
Fair Value
 
Balance Sheet Location
 
Fair Value
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
Interest rate swap contracts
Other assets
 
$
31

 
Other assets
 
$
—

Interest rate swap contracts
Other liabilities
 
$
3,885

 
Other liabilities
 
$
3,843

Effect of Derivative Instruments on the Consolidated Statements of Income (Loss), Comprehensive Loss, and Balance Sheets
The following table presents information about the effects of the Company’s derivative instruments on the consolidated statements of income and consolidated statements of comprehensive income (loss):
 
Location of Gain Recognized in Net Income
 
Amount of Gain Recognized in Net Income
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
 
2017
 
2016
 
2017
 
2016
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
Interest rate swap contracts
Other expenses, net
 
$
(28
)
 
$
(74
)
 
$
(206
)
 
$
(227
)
The following table summarizes the pre-tax amount of unrealized gain or loss recognized in accumulated other comprehensive income (loss), net (“AOCI”) in the Company’s consolidated balance sheets:    
 
Nine Months Ended
 
September 30, 2017
Derivatives Designated as Hedging Instruments:
 
     Accumulated loss in AOCI at the beginning of the period
$
(2,042
)
            Unrealized gain recognized in AOCI
535

            Loss reclassified from AOCI to other expenses, net
(615
)
     Accumulated loss in AOCI at the end of the period
$
(2,122
)